The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Baseline phosphoproteomic signatures in peripheral blood and prediction of durable response to CAR T-cell therapy in B-cell malignancies.
 
Christian Gordillo
No Relationships to Disclose
 
Weronika Borek
Employment - Kinomica Limited
Stock and Other Ownership Interests - Kinomica Limited
Patents, Royalties, Other Intellectual Property - patent with Kinomica Ltd
Travel, Accommodations, Expenses - Kinomica Limited
 
Federico Pedicona
Employment - Kinomica Limited
Stock and Other Ownership Interests - Kinomica Limited
Travel, Accommodations, Expenses - Kinomica Limited
 
Amy Campbell
Employment - Kinomica Limited
Stock and Other Ownership Interests - Kinomica Limited
Travel, Accommodations, Expenses - Kinomica Limited
 
Edmund Wilkes
Employment - Kinomica Limited
Leadership - Kinomica Limited
Stock and Other Ownership Interests - Kinomica Limited
Research Funding - Kinomica Limited
Patents, Royalties, Other Intellectual Property - Named inventor on patents relating to Kinomica's operations
Travel, Accommodations, Expenses - Kinomica Limited
 
Arran Dokal
Employment - Kinomica Limited
Leadership - Kinomica Limited
Stock and Other Ownership Interests - Kinomica Limited
Research Funding - Kinomica Limited
Patents, Royalties, Other Intellectual Property - I am a named inventor on biomarker patents. (Inst)
Travel, Accommodations, Expenses - Kinomica Limited
 
Ran Reshef
Consulting or Advisory Role - Allogene Therapeutics; Autolus Therapeutics; CareDX; Gilead Sciences; Incyte; Orca Bio; Pierre Fabre; Sail Biomedicines; Sail Biomedicines; Sail Biomedicines; Sana Biotechnology; TScan Therapeutics
Research Funding - Abbvie (Inst); Allogene Therapeutics (Inst); Arcellx (Inst); AstraZeneca (Inst); Atara Biotherapeutics (Inst); Bristol-Myers Squibb (Inst); Cabaletta Bio (Inst); CareDX (Inst); Genentech/Roche (Inst); Gilead Sciences (Inst); immatics (Inst); Imugene (Inst); Incyte (Inst); Janssen (Inst); Kinomica Limited (Inst); Sanofi (Inst); Sonoma Biotherapeutics (Inst); Synthekine (Inst); Takeda (Inst); TScan Therapeutics (Inst); Vittoria Therapeutics (Inst)
Expert Testimony - Bayer
Travel, Accommodations, Expenses - Gilead Sciences